Phase 1 Anxiety Disorder Clinical Trials
9 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–9 of 9 trials
Recruiting
Phase 1
ACT for Individuals With MNCD and Their Care Partners
Depression in AdultsAnxiety Disorder GeneralizedGrief
Texas Tech University100 enrolled1 locationNCT07239609
Not Yet Recruiting
Phase 1
Testing the Safety and Effects of the Psychedelic Psilocin on Wellbeing and Anxiety in People with Ongoing Physical and Mental Health Conditions
Chronic Fatigue SyndromeAnorexia NervosaFibromyalgia+6 more
Tryptamine Therapeutics66 enrolled1 locationACTRN12625000949482
Recruiting
Phase 1Phase 2
Roxadustat for Bone and Neuropsychiatric Aspects in Hemodialysis Patients
Depression Anxiety DisorderKidney Failure, ChronicAnemia in End Stage Renal Disease
Mansoura University46 enrolled1 locationNCT06917950
Completed
Phase 1
A study of RLS103 (CBD-Technosphere® Inhalation Powder) in Healthy Adult Volunteers
Social Anxiety DisorderPanic Disorder
Receptor Life Sciences Australia Pty Ltd30 enrolled1 locationACTRN12621001365853
Completed
Phase 1
A Multiple Dose Study Evaluating the Pharmacokinetics of an Oral Tablet Formulation of BNC210 in Healthy Volunteers
Anxiety Disorders
Bionomics Limited20 enrolled1 locationACTRN12621000125820
Active
Phase 1
Acceptance and Commitment Therapy (ACT) to enhance stress resilience in police recruits: A randomized control trial
DepressionSubstance Use DisordersAnxiety Disorders
Australian National University160 enrolled1 locationACTRN12611000270910
Completed
Phase 1
The effect of food on the pharmacokinetcs, tolerability and pharmacodynamics of BNC210 in healthy male volunteers
Generalised Anxiety Disorder
Bionomics Limited4 enrolled1 locationACTRN12610000442000
Completed
Phase 1
The pharmacokinetics and clinical tolerability of ascending single doses of BNC210, an anxiolytic compound, in healthy volunteers
Generalised Anxiety Disorder
Bionomics Limited4 enrolled1 locationACTRN12609000577213
Not Yet Recruiting
Phase 1
A randomised controlled trial of a letter intervention in primary care patients to improve depression and anxiety disorders
DSM-IV Axis 1 Depressive and Anxiety Disorders
The Alfred Hospital200 enrolled1 locationACTRN12606000111572